Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Úna C. McMenamin"'
Autor:
Chloe A. McCoy, Helen G. Coleman, Charlene M. McShane, W. Glenn McCluggage, James Wylie, Declan Quinn, Úna C. McMenamin
Publikováno v:
PLoS ONE, Vol 19, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/f138deb541014e46875e16ec0570a571
Autor:
Lauren McVicker, Christopher R. Cardwell, Lauren Edge, W Glenn McCluggage, Declan Quinn, James Wylie, Úna C. McMenamin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Diabetes is an established risk factor for endometrial cancer development but its impact on prognosis is unclear and epidemiological studies to date have produced inconsistent results. We aimed to conduct the first systematic revi
Externí odkaz:
https://doaj.org/article/51bcf2bb429e426b99b9241d788cd051
Autor:
Peipei Liu, Úna C. McMenamin, Andrew D. Spence, Brian T. Johnston, Helen G. Coleman, Chris R. Cardwell
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Pre-clinical studies have shown that furosemide slows cancer cell growth by acting on the Na-K-2Cl transporter, particularly for gastric cancer cells. However, epidemiological studies have not investigated furosemide use and morta
Externí odkaz:
https://doaj.org/article/1191dd6cde1b4efb8e60f0809c482a43
Autor:
Andrew D. Spence, Chris R. Cardwell, Úna C. McMenamin, Blanaid M. Hicks, Brian T. Johnston, Liam J. Murray, Helen G. Coleman
Publikováno v:
BMC Gastroenterology, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Gastric cancer (GC) has a poor prognosis with wide variation in survival rates across the world. Several studies have shown premalignant lesions gastric atrophy (GA) and intestinal metaplasia (IM) influence gastric cancer risk. Th
Externí odkaz:
https://doaj.org/article/aea39d0c6b7142a9850a642099d1de3f
Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study
Publikováno v:
McVicker, L, Cardwell, C R, McIntosh, S A & McMenamin, Ú C 2022, ' Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study ', Breast Cancer Research and Treatment, vol. 195, no. 2, pp. 209-221 . https://doi.org/10.1007/s10549-022-06674-5
Purpose Epidemiological studies have indicated a higher prevalence of hypothyroidism in breast cancer patients, possibly related to shared risk factors and breast cancer treatments. However, few studies have evaluated how hypothyroidism impacts survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c422c00102948f39a48627d186d5648e
https://doi.org/10.1007/s10549-022-06674-5
https://doi.org/10.1007/s10549-022-06674-5
Autor:
Marie M. Cantwell, Úna C. McMenamin, Charlene M. McShane, Chris R. Cardwell, Liam J. Murray, Andrew T. Kunzmann
PDF file - 42K, A table that summarises the studies included in the systematic review.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16601379f8f9686bd2c380643375574b
https://doi.org/10.1158/1055-9965.22436128.v1
https://doi.org/10.1158/1055-9965.22436128.v1
Autor:
Marie M. Cantwell, Úna C. McMenamin, Charlene M. McShane, Chris R. Cardwell, Liam J. Murray, Andrew T. Kunzmann
Background: Studies have examined whether tumor expression of PTGS2 (also known as COX-2), an enzyme inhibited by nonsteroidal anti-inflammatory drugs such as aspirin, is associated with prognosis in patients with colorectal cancer. However, results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6c643b95651cbfb1f846b5f55aebdc
https://doi.org/10.1158/1055-9965.c.6515245
https://doi.org/10.1158/1055-9965.c.6515245
Autor:
Michael B. Cook, Marie M. Cantwell, Peipei Liu, Helen G Coleman, Úna C. McMenamin, Brian T. Johnston, Andrew T. Kunzmann, Christopher Cardwell
Publikováno v:
Am J Gastroenterol
McMenamin, Ú, Liu, P, Kunzmann, A, Cook, M, Coleman, H, Johnston, B, Cantwell, M & Cardwell, C 2020, ' Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank ', The American Journal of Gastroenterology, vol. 2020, pp. 1 . https://doi.org/10.14309/ajg.0000000000001045
McMenamin, Ú, Liu, P, Kunzmann, A, Cook, M, Coleman, H, Johnston, B, Cantwell, M & Cardwell, C 2020, ' Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank ', The American Journal of Gastroenterology, vol. 2020, pp. 1 . https://doi.org/10.14309/ajg.0000000000001045
INTRODUCTION: Gastrointestinal cancers show an unexplained male predominance, but few prospective studies have investigated sex hormones and gastrointestinal cancer risk. This study aimed to determine the impact of circulating sex hormones on risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746dc48154cda1a0258c7517671e22f1
https://doi.org/10.14309/ajg.0000000000001045
https://doi.org/10.14309/ajg.0000000000001045
Autor:
Pauline A. J. Vissers, Brian T. Johnston, Peipei Liu, Lisa Iversen, Amanda J Lee, Peter Murchie, Christopher Cardwell, Úna C. McMenamin
Publikováno v:
British Journal of Cancer
Liu, P, McMenamin, Ú C, Johnston, B T, Murchie, P, Iversen, L, Lee, A J, Vissers, P A J & Cardwell, C R 2020, ' Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-0860-4
Liu, P, McMenamin, Ú C, Johnston, B T, Murchie, P, Iversen, L, Lee, A J, Vissers, P A J & Cardwell, C R 2020, ' Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-0860-4
Background Studies have shown increased gastric cancer risk in users of proton pump inhibitors (PPI) and histamine-2 receptor antagonists, questioning the safety of gastric acid suppression. Therefore, we conducted a case–control study within the S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e3079550c43ea368a27a5ce65d7324
https://doi.org/10.1038/s41416-020-0860-4
https://doi.org/10.1038/s41416-020-0860-4
Autor:
Joe M. O'Sullivan, Úna C. McMenamin, Michael B. Cook, Suneil Jain, Mark Harbinson, Blánaid Hicks, Christopher Cardwell
Publikováno v:
Cardwell, C R, O'Sullivan, J M, Jain, S, Harbinson, M T, Cook, M B, Hicks, B M & McMenamin, U C 2019, ' The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies ', Epidemiology, vol. 31, no. 3, pp. 432 . https://doi.org/10.1097/EDE.0000000000001132
Epidemiology
Epidemiology
Background Androgen deprivation therapy (ADT), which has a proven role in prostate cancer management, has been associated with various cardiovascular diseases. However few studies have investigated these associations by type of ADT, particularly for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec42a9730f72840fab1865a471ada90c
https://doi.org/10.1097/ede.0000000000001132
https://doi.org/10.1097/ede.0000000000001132